Michael Tadao Inouye/LinkedIn, David Hunter/ariadnelabs.org
Sep 26, 2026, 15:42
Michael Tadao Inouye: The Next Frontier in Genomic Population Health
Michael Tadao Inouye, Director of Postgraduate Education (Research), Strand Lead – Molecular Informatics Resources and Tools at University of Cambridge, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in NEJM, adding:
“It’s been a long time coming but delighted to see that the NEJM Group review from David Hunter and me is out!
‘Clinical Uses of Common Genetic Variants Associated with Common Diseases.’
The next 10 years will be a very exciting time for genomic population health.”
Title: Clinical Uses of Common Genetic Variants Associated with Common Diseases
Authors: David J. Hunter, Michael Inouye
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis
-
Sep 26, 2026, 15:27Berkan Kurt: The Role of Biomarkers in Cardiovascular Prevention
-
Sep 26, 2026, 15:21Consuela A. Albright: Five Concrete Ways Steps to Advocate for Sickle Cell Disease
-
Sep 26, 2026, 15:09New ASH Funding Opportunities for Hematology Researchers